Frandsen Mai, Thow Megan, Ferguson Stuart G
School of Health Science, Faculty of Health, University of Tasmania, Launceston, Australia.
School of Medicine, Faculty of Health, University of Tasmania, Hobart, Australia.
JMIR Res Protoc. 2017 Oct 31;6(10):e209. doi: 10.2196/resprot.7907.
Smoking tobacco remains the most significant modifiable cause of adverse pregnancy outcomes and contributor to ongoing maternal and infant ill-health. Pregnancy for many is a time of heightened health focus, with the primary motivation being the well-being of the unborn child. Yet, many women continue to smoke throughout their pregnancy. Despite this heightened motivation and known health risks, interventions to date have not effectively curbed the rate of smoking during pregnancy and they remain as high as rates among the general population. One promising strategy has been to incentivize these women to quit. However, incentives-based studies have not shown or reported long-term efficacy. Here, we present the protocol of a trial exploring the effect of incentivized partner support on pre- and postpartum smoking cessation.
The aim of this study is to determine whether providing incentives to both the expectant mother and her support person in promoting short- and long-term smoking cessation during pregnancy is more effective than incentives to the expectant mother alone.
This protocol is designed as a non-randomized, single-blinded trial to determine the efficacy of incentivized partner support, compared to participant incentive only, in promoting smoking cessation during pregnancy and postpartum. All eligible pregnant women receiving antenatal care via the Tasmanian Health Service (Australia) will be invited to participate. Participants will be eligible for monthly quit-contingent shopping vouchers if they verify, via carbon monoxide breath sample, as being abstinent from smoking. Participating women will be eligible for vouchers until 6-months postpartum and will be followed up at 12-months postpartum.
The recruitment phase of this study has concluded. Results are expected to be published by the end of 2018.
This study protocol extends the current literature on incentivized smoking cessation interventions for pregnant women by assessing the influence of incentivizing a support partner on short- and long-term abstinence. Key ethical considerations are discussed including potential for receipt (or not) of quit-contingent vouchers impacting negatively on the participant's relationship with their partner. The findings of the study may have important implications for the role support partners are assigned in smoking cessation programs targeting pregnant women.
Australian New Zealand Clinical Trials Registry (ACTRN): 12615001158550; https://www.anzctr.org.au/ Trial/Registration/TrialReview.aspx?id=367981 (Archived by WebCite at http://www.webcitation.org/6tGKO28uh).
吸烟仍然是导致不良妊娠结局的最主要可改变因素，也是造成孕产妇和婴儿持续健康问题的原因。对许多人来说，怀孕是一个更加关注健康的时期，主要动机是未出生孩子的健康。然而，许多女性在整个孕期仍继续吸烟。尽管有这种增强的动机以及已知的健康风险，但迄今为止的干预措施尚未有效遏制孕期吸烟率，其仍与普通人群中的吸烟率一样高。一种有前景的策略是激励这些女性戒烟。然而，基于激励措施的研究尚未显示或报告长期效果。在此，我们介绍一项试验的方案，该试验旨在探究激励性伴侣支持对产前和产后戒烟的影响。
本研究的目的是确定在促进孕期短期和长期戒烟方面，同时向准妈妈及其支持人员提供激励措施是否比仅对准妈妈提供激励措施更有效。
本方案设计为一项非随机、单盲试验，以确定与仅给予参与者激励措施相比，激励性伴侣支持在促进孕期和产后戒烟方面的效果。所有通过塔斯马尼亚卫生服务机构（澳大利亚）接受产前护理的符合条件的孕妇将被邀请参与。如果参与者通过一氧化碳呼气样本验证为戒烟，他们将有资格获得每月与戒烟挂钩的购物券。参与的女性在产后6个月内都有资格获得购物券，并将在产后12个月接受随访。
本研究的招募阶段已结束。预计结果将于2018年底公布。
本研究方案通过评估激励支持伴侣对短期和长期戒烟的影响，扩展了当前关于激励孕妇戒烟干预措施的文献。讨论了关键的伦理考量，包括获得（或未获得）与戒烟挂钩的购物券可能对参与者与其伴侣的关系产生负面影响。该研究的结果可能对支持伴侣在针对孕妇的戒烟项目中所扮演的角色具有重要意义。
澳大利亚新西兰临床试验注册中心（ACTRN）：12615001158550；https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=367981（由WebCite存档于http://www.webcitation.org/6tGKO28uh）。
